HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fatemeh Rahimi Jamnani Selected Research

Infections

8/2018The inhibitory effect of the combination of two new peptides on biofilm formation by Acinetobacter baumannii.
10/2017The impact of genetic variation in IL28B, IFNL4 and HLA genes on treatment responses against chronic hepatitis C virus infection.
9/2017Effect of IL15 rs10833 and SCARB1 rs10846744 on virologic responses in chronic hepatitis C patients treated with pegylated interferon-α and ribavirin.
1/2017IL28B rs12980275 and HLA rs4273729 genotypes as a powerful predictor factor for rapid, early, and sustained virologic response in patients with chronic hepatitis C.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fatemeh Rahimi Jamnani Research Topics

Disease

4Infections
08/2018 - 01/2017
4Neoplasms (Cancer)
07/2017 - 06/2012
3Chronic Hepatitis C
10/2017 - 01/2017
2Virus Diseases (Viral Diseases)
10/2017 - 01/2017
1Anaphylaxis (Anaphylactic Shock)
12/2016
1Breast Neoplasms (Breast Cancer)
06/2012

Drug/Important Bio-Agent (IBA)

3AntigensIBA
01/2014 - 06/2012
2Ribavirin (Virazole)FDA LinkGeneric
10/2017 - 09/2017
2HLA Antigens (Human Leukocyte Antigens)IBA
10/2017 - 01/2017
2InterferonsIBA
10/2017 - 09/2017
2Antigen Receptors (Antigen Receptor)IBA
01/2014 - 07/2013
2Single-Domain AntibodiesIBA
07/2013 - 06/2012
1Peptides (Polypeptides)IBA
08/2018
1Anti-Bacterial Agents (Antibiotics)IBA
08/2018
1Viral Protease InhibitorsIBA
10/2017
1Interferon LambdaIBA
10/2017
1CytokinesIBA
09/2017
1Scavenger Receptors (Scavenger Receptor)IBA
09/2017
1Interleukin-15 (Interleukin 15)IBA
09/2017
1DNA (Deoxyribonucleic Acid)IBA
07/2017
1Immune Sera (Antisera)IBA
12/2016
1VenomsIBA
12/2016
1Chimeric Antigen ReceptorsIBA
01/2014
1AntibodiesIBA
01/2014
1Glycoproteins (Glycoprotein)IBA
07/2013
1tumor-associated antigen 72IBA
07/2013
1EpitopesIBA
06/2012
1Trastuzumab (Herceptin)FDA Link
06/2012

Therapy/Procedure

5Therapeutics
10/2017 - 06/2012
1Cell- and Tissue-Based Therapy (Cell Therapy)
01/2014
1Immunotherapy
01/2014